Phacilitate Leaders World

Speakers

Loading
Keith  Knutson

Keith Knutson

Director, Cancer Vaccine & Immune Therapies Program, Mayo Clinic

Dr. Keith L. Knutson is currently Professor in the Department of Immunology at Mayo Clinic in Jacksonville and Director, Mayo Clinic Florida Cancer Research Program.  He received his Ph.D. from the University of Georgia in Physiology and Pharmacology in 1995 and completed two post-doctoral fellowships in immunology, one at the University of British Columbia and the other at the University of Washington. He was a 2004 recipient of a Howard Temin Award from the National Cancer Institute.  Dr. Knutson’s current interests and research focuses on the immunology and immunotherapy of breast and ovarian cancers.  Interests are in both the basic immunobiology and clinical translation, including clinical trials.  The laboratory conducts research on cancer vaccines focuses on augmenting T cell immunity using peptide and virus-based vaccines.  These vaccine strategies are primarily aimed at preventing the patients from relapsing after optimal conventional therapies.   Dr. Knutson is currently (1) a member of the Tumor Microenvironment Study Section at the Center for Scientific Review at the National Institutes of Health, (2) a member of the Integration Panel of Department of Defense’s Ovarian Cancer Research Program, and (3) a Susan G. Komen Scholar.


 

Testimonials
  • Real thinking forward combining experts in the field from manufacturing, regulatory and value vision” – “great network with strong experience and sharing risks & opportunities
    Anne-Virginie Eggimann
    bluebird bio
  • Great program, great people, great venue.
    Klaus Kühlcke
    EUFETS GmbH
  • Dynamic, interesting and highly interactive event that promotes exchange and networking in highly specialized field of gene therapy.
    Nathalie Clement
    Powell Gene Therapy Center, University of Florida
  • Phacilitate provides a unique forum, bringing together research, process development, and commercial leaders on the cutting edge of cell, gene, and immunotherapy. A great conference for anyone wanting a comprehensive view of the field.
    Dr James Trager
    Dendreon
  • It was all business. I’ve never been to an event where over 80% of the conversations I had were constructive to my business objectives.
    Kurt Gielen
    Chemelot Campus B.V.
  • Great way to expand network with global experts in cell and gene therapy who are facing similar challenges.
    Steven Goodman
    GSK